Our findings emphasize the intricate mechanisms by which IGF-1R contributes to various aspects of lung cancer pathogenesis, including tumor proliferation, metastasis, EMT, stemness, and resistance to both chemotherapy and targeted therapies. The gene discussed is IGF1R; the disease is lung carcinoma.